The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus

Excessive Production of IFN-  in Patients with Systemic Lupus Erythematosus and Its Contribution to Induction of B Lymphocyte Stimulator/B Cell-Activating Factor/TNF Ligand Superfamily-13B

(2014) M. Harigai et al.   JOURNAL OF IMMUNOLOGY

Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL

(2014) M. J. Benson et al.   JOURNAL OF IMMUNOLOGY

New approaches of B-cell-directed therapy: beyond rituximab

(2009) Thomas Dörner et al.   CURRENT OPINION IN RHEUMATOLOGY

The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders

(2008) D-A Landau et al.   ANNALS OF THE RHEUMATIC DISEASES

Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo-controlled, dose-ranging study

(2008) Mark C. Genovese et al.   ARTHRITIS AND RHEUMATISM

APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells

(2008) E. Belnoue et al.   BLOOD

B cells flying solo

(2008) Joanna Groom et al.   IMMUNOLOGY AND CELL BIOLOGY

Tonic B cell antigen receptor signals supply an NF-κB substrate for prosurvival BLyS signaling

(2008) Jason E Stadanlick et al.   NATURE IMMUNOLOGY

BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact

(2008) J. L. Scholz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

B cells as therapeutic targets in autoimmune neurological disorders

(2008) Marinos C Dalakas   Nature clinical practice. Neurology

Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus

(2007) M Nikpour et al.   ANNALS OF THE RHEUMATIC DISEASES